Delivery Order SPE2DB22D3501-SPE2DB24FWA59
Award Date
6/20/24
Potential Completion Date
6/21/24
Potential Value
$5.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,220.99, is for the delivery of ERYTHROMYCIN 0.5% EYE OINTMENT. The contract is a Firm Fixed Price Delivery Order with a completion date of March 21, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567678980 ERYTHROMYCIN 0.5% EYE OINTMENT 3.5GM, with a ceiling value of $3,043.92 and a completion date of March 25, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a $1,032.50 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4564804557 - Erythromycin 0.5% eye ointment, 3.5 gm. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Erythromycin 0.5% eye ointment. The award has a ceiling value of $2,822.73 and a completion date of November 20, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,267.92, is a Delivery Order for the procurement of ERYTHROMYCIN 0.5% EYE OINTMENT 3.5GM. The contract has an ultimate completion date of December 26, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, is for the supply of 4564854474 ! ERYTHROMYCIN 0.5% EYE OINTMENT UDGM to the Defense Logistics Agency (DLA). The contract, valued at $16,536.36, is a firm fixed-price delivery order with a completion date of June 11, 2024. The contract is not set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ERYTHROMYCIN 0.5% EYE OINTMENT 3.5GM. The potential value of this contract is $1,156.68 and the performance period runs through February 15, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this contract, which was not set aside for any specific business type. This order...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Erythromycin 0.5% eye ointment. The contract has a firm fixed price of $1,031.72 and a performance period ending on August 12, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation. The contract is a delivery order issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen...
This federal contract award, valued at $2,156.22, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4564288312 - ERYTHROMYCIN 0.5% EYE OINTMENT 3.5GM, with a completion date of April 16, 2024. This is a delivery order contract awarded on a firm fixed price basis. Amerisourcebergen Drug Corp, as a major supplier of pharmaceutical products and medical supplies to...
This federal contract award is for the delivery of ERYTHROMYCIN 0.5% EYE OINTMENT to the Defense Logistics Agency, a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $1,511.14. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has a period of performance ending on July 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...